Linagliptin, Empagliflozin for Cardiovascular risk reduction in T2DM

Glyxambi

Diabetes

25/5mg

4.9 per tablet
The Linagliptin, Empagliflozin for Cardiovascular risk reduction in T2DM tag is here to improve navigation and help you find relevant information quickly.
Categories